Parathyroid Hormone and Ischemic Cerebrovascular Event.

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Neurology

Background:

• Elevated parathyroid hormone (PTH) is linked to cardiovascular risk factors like hypertension and left ventricular hypertrophy, which predispose individuals to ischemic cerebrovascular events (ICVE).
• Carotid intima-media thickness (CIMT) and aortic distensibility are established early indicators of subclinical atherosclerosis.
• The association between PTH levels and these atherosclerosis markers in ICVE patients remained uninvestigated prior to this study.

Purpose of the Study:

• To investigate the relationship between parathyroid hormone (PTH) levels and measures of atherosclerosis, specifically CIMT and aortic distensibility, in patients with ICVE.

Main Methods:

• The study included 64 patients diagnosed with ICVE and a control group of 50 individuals.
• Parathyroid hormone (PTH) levels, carotid intima-media thickness (CIMT), and aortic distensibility were measured in all participants.

Main Results:

• Patients with ICVE exhibited significantly higher PTH levels compared to the control group (p=0.008).
• PTH levels demonstrated a significant inverse correlation with aortic distensibility (r=-0.420, p=0.001).
• A significant positive correlation was observed between PTH levels and CIMT (r=0.285, p=0.002).

Conclusions:

• This study demonstrates that individuals with acute ischemic cerebrovascular events have elevated parathyroid hormone (PTH) levels.
• The findings indicate an inverse relationship between PTH levels and aortic distensibility, and a positive association with CIMT in ICVE patients.
• Elevated PTH may serve as a potential biomarker for subclinical atherosclerosis in the context of ischemic cerebrovascular events.